(IN BRIEF) Almirall has entered into a collaboration and licensing agreement with CrystalO for the discovery and development of novel small molecules in medical dermatology. Under the agreement, CrystalO will handle candidate discovery, optimisation, IND-enabling studies and early clinical development, … Read the full press release →
Posted in Business, Healthcare, International Trade, Investment, Pharma & Biotech, Science, Spain, Technology
Tagged Almirall, Almirall and CrystalO Enter Licensing Agreement for Dermatology Drug Discovery, Almirall Expands Medical Dermatology Pipeline Through CrystalO Collaboration, Almirall Partners With CrystalO to Develop Novel Small Molecules in Medical Dermatology, candidate discovery, candidate optimisation, clinical proof of concept, collaboration agreement, Commercialisation, CrystalO, Dermatology, dermatology treatments, differentiated treatments, Dr Zhang Jin, drug discovery, early clinical development, exclusive rights outside mainland China, external innovation, Global Development, IND-enabling studies, innovation strategy, innovative medicines, ion channel drug discovery, Karl Ziegelbauer, licensing agreement, local R&D programmes, Mainland China, Manufacturing, medical dermatology, novel small molecules, patient benefits, pharmaceutical research, PoC, R&D Pipeline, scientific collaboration, skin conditions, small molecule discovery, strategic collaboration, technology platform, therapeutic development, unmet medical need
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
